Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2010
06/30/2010CN101756941A Drug-reservoir type scar-removing silicone gel paster and preparation method thereof
06/30/2010CN101756939A Dexketoprofen coating sustained-release micro-encapsulated capsule
06/30/2010CN101756936A Oral antiviral medicament
06/30/2010CN101756921A Hydroxyurea tablet and preparation method thereof
06/30/2010CN101756915A Tirofiban hydrochloride lyophilized powder injection and preparation method thereof
06/30/2010CN101756914A Omeprazole sodium frozen powder injection and preparation method thereof
06/30/2010CN101756912A Hemocoagulase freeze-dried powder injection and preparation method thereof
06/30/2010CN101756910A Lung targeting ceftiofur microsphere and preparation method
06/30/2010CN101756909A Lung-targeting ceftiofur microsphere and preparation method thereof
06/30/2010CN101756908A Hydroxyapatite micro-sphere with polyester coating and preparation method thereof
06/30/2010CN101756907A Oral solid preparation containing polyene phosphatidyl choline and preparation method thereof
06/30/2010CN101756904A Preparation process for chitosan microsphere
06/30/2010CN101756903A Preparation process of nanometer magnetic drug-carrying gene-carrying thermal controlled release liposome
06/30/2010CN101756901A Hydrofluoroalkane aerosol containing lidocaine
06/30/2010CN101756899A Valnemulin nano-emulsion antibacterial medicine preparation
06/30/2010CN101756898A Lansoprazole sodium suspension preparation for injection and new application thereof
06/30/2010CN101756897A Clindamycin hydrochloride injection and preparation method thereof
06/30/2010CN101756896A Kudzu-vine root daidzein-7, 4'-dioxo acetic acid compound transfusion formula and preparation method thereof
06/30/2010CN101756895A Polyene phosphatidyl choline intravenous preparation and preparation method thereof
06/30/2010CN101756888A Temperature-controlled sustained-release injection containing isoliquiritigenin and preparation method thereof
06/30/2010CN101756887A Shell-crosslinked polymeric micelles by using metal nanoparticles as crosslinking agent
06/30/2010CN101756885A Displeased taste and oral liquid preparation with reduced odor
06/30/2010CN101338045B Technique of preparing cassava starch plant gum, the plant gum prepared thereby and plant capsules
06/30/2010CN101322848B Composition for gastroscopy and preparation thereof
06/30/2010CN101244045B Zero level drug administration oral controlled-release tablet and preparation thereof
06/30/2010CN101095669B Osthole phospholipid complexes and method for preparing the same and application thereof
06/30/2010CN101084874B Method for preparing water soluble hypocrellin silica nanometer particle and its application in preparing venous injection
06/30/2010CN101077343B Dexibuprofen granule and preparation method thereof
06/29/2010US7745651 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity
06/29/2010US7745606 polynucleotides used for modulating immune responses; immunotherapy
06/29/2010US7745430 Comprising diazepam as an active ingredient, water, a fatty acid ester, diethylene glycol monoethyl ether, ethanol and sodium glycocholate, wherein the weight of the fatty acid ester is at least 2-fold higher than that of water and at least 2-fold higher than that of ethanol; epilepsy treatment
06/29/2010US7745394 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases
06/29/2010US7745388 Peptide for use in the treatment of cell damage caused by ischemia
06/29/2010US7745114 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
06/29/2010US7744922 Film forming envelope encloding core; food, drugs, oral hygiene, cosmetics
06/29/2010US7744921 Liposome loading with metal ions
06/29/2010US7744912 Forming a biopolymer by polymerization or crosslinking through self-selective reaction between a strong multifunctional nucleophile such as amine or thiol and a conjugated unsaturated bond; preparation of highly biomimetic synthetic polymers
06/29/2010US7744910 Compounds and compositions for delivering active agents
06/29/2010US7744909 Dispersions for the formulation of slightly or poorly soluble agents
06/29/2010US7744895 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects
06/29/2010US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/29/2010US7744877 Administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies for treating B cell lymphoma
06/29/2010US7744870 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs
06/29/2010US7744861 Multi-arm polymer prodrugs
06/29/2010US7744855 Milling particles for use in inhalable pharmaceuticals
06/29/2010US7744853 Radiolabeled annexins
06/29/2010CA2636421C A method of platelet and whole blood storage
06/29/2010CA2538856C Transdermal pharmaceutical formulation for minimizing skin residues
06/29/2010CA2504065C Dispersible antibacterial pharmaceutical compositions
06/29/2010CA2461576C Process for the preparation of tablets comprising s-adenosylmethionine
06/29/2010CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/29/2010CA2453117C Oral dosage forms comprising a benzimidazole and buffer
06/29/2010CA2452471C Enhancement of transfection of dna into the liver
06/29/2010CA2426885C Complexes of phosphate derivatives
06/29/2010CA2424596C Oral self-emulsifying formulations of pyranone protease inhibitors
06/29/2010CA2415280C Use of halogenated xanthenes as anti-cancer and anti-bacterial agents
06/29/2010CA2406373C Controlled release paracetamol composition
06/29/2010CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
06/29/2010CA2401942C Pharmaceutical compositions for buccal and pulmonary application
06/29/2010CA2387746C Methods for stabilizing benzimidazole-based compounds
06/29/2010CA2382389C Pharmaceutically stable oxaliplatinum preparation for parenteral administration
06/29/2010CA2379734C Treatment of cancers
06/29/2010CA2370225C Highly purified gonadotropin compositions and process for preparing them
06/29/2010CA2312188C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/29/2010CA2195169C Transfection competent molecules
06/29/2010CA2187346C Receptor modulating agents and methods relating thereto
06/24/2010WO2010071593A1 Delivery system for delivery of a substance into the oral cavity
06/24/2010WO2010071320A2 Controlled-release composition for producing sustained-release preparation containing udenafil
06/24/2010WO2010071232A1 A disintegrating tablet
06/24/2010WO2010071230A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
06/24/2010WO2010071217A1 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
06/24/2010WO2010071210A1 Chondrocyte-like cell, and method for producing same
06/24/2010WO2010071190A1 Heparin affinity erythropoietin
06/24/2010WO2010070705A1 Aqueous oral preparation of stable amlodipine
06/24/2010WO2010070617A1 Inclusion complexes of alpha-cyclodextrin and sildenafil salt
06/24/2010WO2010070300A2 Functionalising reagents and their uses
06/24/2010WO2010070236A1 Formulation for the buccal transmucosal administration of setrons
06/24/2010WO2010070210A1 Pharmaceutical composition containing an n-phenylpyrazole derivative, and use thereof for preparing a topical veterinary drug for flea control
06/24/2010WO2010070141A2 Compositions comprising adipose stem cells
06/24/2010WO2010069941A1 Conjugates comprising nanoparticles coated with platinum containing compounds
06/24/2010WO2010069507A1 Nicotine-containing product
06/24/2010WO2010069140A1 Medicinal product of oryzanol and preparation method thereof
06/24/2010WO2010069139A1 Pharmaceutical composition and preparation method thereof
06/24/2010WO2010069138A1 Oryzanol composition and preparation method thereof
06/24/2010WO2010069060A1 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
06/24/2010WO2010069050A1 Misuse preventative, controlled release formulation
06/24/2010WO2010046917A3 Fludarabine phosphate composition
06/24/2010WO2010043972A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury
06/24/2010WO2010043444A3 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury
06/24/2010WO2010037856A3 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS
06/24/2010WO2010026483A3 Conjugate of a chitin derivative with natural sweeteners for controlling ingested fats in humans and having sweetening properties
06/24/2010WO2010025324A3 Nanoparticles for immunotherapy
06/24/2010WO2010018596A3 Stable injectable oil-in-water docetaxel nanoemulsion
06/24/2010WO2010016912A3 Immunotherapeutic compositions for the treatment of alzheimer's disease
06/24/2010WO2010010112A3 Construct and method for the internalization of cargo molecules into a cell
06/24/2010US20100160895 Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents
06/24/2010US20100160484 Xanthene-based plasticizer of resins and polymers
06/24/2010US20100160437 Topical composition comprising a cyclofructan, a carrier and a drug
06/24/2010US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use
06/24/2010US20100160400 Treatment using dantrolene